NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,833 Cr | ₹1,580 Cr | ₹1,383 Cr | ₹1,325 Cr | ₹1,231 Cr |
What is the latest Total Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,833 Cr |
Mar2023 | ₹1,580 Cr |
Mar2022 | ₹1,383 Cr |
Mar2021 | ₹1,325 Cr |
Mar2020 | ₹1,231 Cr |
How is Total Liabilities of NEULAND LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,833 Cr | 16.00 | |
Mar2023 | ₹1,580 Cr | 14.19 | |
Mar2022 | ₹1,383 Cr | 4.43 | |
Mar2021 | ₹1,325 Cr | 7.62 | |
Mar2020 | ₹1,231 Cr | - |
Compare Total Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹18,524.4 Cr | 2.1% | -1% | 134.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,084.0 Cr | -0% | -4.6% | 18.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,384.0 Cr | 8.8% | 5.1% | 64.4% | Stock Analytics | |
CIPLA | ₹118,853.0 Cr | 2.4% | -1.1% | 0.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,143.0 Cr | 2.6% | -9.9% | -0.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,459.0 Cr | 3.6% | -0.1% | 22.7% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 2.1% |
-1% |
134.2% |
SENSEX | 0.7% |
-0.1% |
8.8% |
You may also like the below Video Courses